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The current outbreak of the coronavirus disease 2019 (COVID-19) is an unprecedented example
of how fast an infectious disease can spread around the globe (especially in urban areas) and the
enormous impact it causes on public health and socio-economic activities. Despite the recent surge
of investigations about different aspects of the COVID-19 pandemic, we still know little about the
effects of city size on the propagation of this disease in urban areas. Here we investigate how
the number of cases and deaths by COVID-19 scale with the population of Brazilian cities. Our
results indicate that large cities are proportionally more affected by COVID-19, such that every
1% rise in population is associated with 0.57% increase in the number of cases per capita and
0.25% in the number of deaths per capita. The difference between the scaling of cases and deaths
indicates the case fatality rate decreases with city size. The latest estimates show that a 1% increase
in population associates with a 0.14% reduction in the case fatality rate of COVID-19; however,
this urban advantage has decreased over time. We interpret this to be due to the existence of
proportionally more health infrastructure in the largest cities and a lower proportion of older adults
in large urban areas. We also find the initial growth rate of cases and deaths to be higher in large
cities; however, these growth rates tend to decrease in large cities and to increase in small ones
during the long-term course of the pandemic.
INTRODUCTION
Human activities have become increasingly concen-
trated in urban areas. A direct consequence of this world-
wide urbanization process is that more people are living
in cities than in rural regions since 2007 [1], and pro-
jections indicate that the world urban population could
reach more than 90% by the end of this century [2]. Be-
sides being increasingly urbanized, we live in an unprece-
dentedly connected, and highly mobile world with air
passengers exceeding 4 billion in 2018 [3]. On the one
hand, a highly connected and highly urbanized society
brought us innovation, economic growth, more access to
education and healthcare; on the other, it has also lead to
pollution, environmental degradation, privacy concerns,
more people living in substandard conditions, and suit-
able conditions for dissemination of infectious diseases
over the globe. In particular, the emergence of infectious
disease outbreaks has significantly increased over time,
and the majority of these events are caused by pathogens
originating in wildlife [4], which in turn has been associ-
ated with changes in environmental conditions and land
use, agricultural practices, and the rise of large human
population settlements [5].
The ongoing outbreak of the novel coronavirus (SARS-
CoV-2) seems to fit well the previous context as it was
first identified in Wuhan in December 2019, an influen-
tial Chinese city exceeding 11 million inhabitants, and
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apparently originated from the recombination of bat and
Malayan pangolin coronaviruses [6]. The coronavirus dis-
ease 2019 (COVID-19) initially spread in Mainland China
but rapidly caused outbreaks in other countries, making
the World Health Organization first declare a “Public
Health Emergency of International Concern” in January
2020, and in mid-March, the outbreak was reclassified
as a pandemic. As of 25 May 2020, over 5.2 million
cases of COVID-19 have been confirmed in more than
200 countries, and the worldwide death toll exceeds 342
thousand people [7]. The COVID-19 pandemic poses un-
precedented health and economic threats to our society,
and understanding its spreading patterns may find im-
portant factors for mitigating or controlling the outbreak.
Recent works have focused on modeling the initial
spreading of COVID-19 [8] or the fatality curves [9], pro-
jecting the outbreak peak and hospital utilization [10],
understanding the effects of mobility [11], demogra-
phy [12], travel restrictions [13] and behavior change [14]
on the virus transmission, among many others. Despite
the increasing surge of scientific investigations on the sub-
ject, little attention has been paid to understanding the
effects of city size on spreading patterns of cases and
deaths by COVID-19 in urban areas. The idea that size
(as measured by population) affects different city indica-
tors has been extensively studied and can be summarized
by the urban scaling hypothesis [15–18]. This theory
states that urban indicators are non-linearly associated
with city population such that socio-economic indicators
tend to present increasing returns to scale, infrastructure
indicators often display economy of scale, and quantities
related to individual needs usually scale linearly with city
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Urban scaling studies of health-related quantities have
shown that the incidence and mortality of diseases are
non-linearly related to the city population [19–22]. De-
spite the existence of several exceptions [22], noninfec-
tious diseases (such as diabetes) are usually less prevalent
in large cities, while infectious diseases (such as AIDS)
are relatively more common in large urban areas. This
different behavior is likely to reflect the fact that peo-
ple living in large cities tend to have proportionally more
contacts and a higher degree of social interactions than
those living in small towns [16, 23]. Within this context,
the recent work of Stier, Berman, and Bettencourt [24]
has indicated that large cities in the United States experi-
enced more pronounced growth rates of COVID-19 cases
during the first weeks after the introduction of the dis-
ease. This finding has serious consequences for the evo-
lution of COVID-19 and suggests that large metropolises
may become infection hubs with potentially higher and
earlier peaks of infected people. Investigating whether
this behavior generalizes to other places and how differ-
ent quantities such as the number of cases and deaths
scale with city size are thus important elements for a
better understanding of the spreading of COVID-19 in
urban areas.
Here we investigate how population size is associated
with cases and deaths by COVID-19 in Brazilian cities.
Brazil is the sixth most populous country in the world,
with over 211 million people, of which more than 85% live
in urban areas. While it is likely that the novel coron-
avirus was already circulating in Brazil in early February
2020 [25], the first confirmed case in the country dates
back to 26 February 2020, in the city of Sa˜o Paulo. Be-
tween the first case and 25 May 2020, Brazil has con-
firmed 347,398 cases of COVID-19 (second-largest num-
ber) spread out over 67% of the 5,570 Brazilian cities.
This disease caused 20,013 deaths (sixth-largest number)
with 1,568 cities reporting at least one casualty as of 25
May 2020. These numbers make Brazil the next likely
epicenter of this disease [26], and its dynamics may im-
pact the overall outcome of the COVID-19 pandemic.
RESULTS
We start by briefly presenting our data set (see Meth-
ods for details). Our investigations rely on the daily re-
ports published by the Health Offices of each of the 27
Brazilian federative units. These daily reports update the
number of confirmed cases (Yc) and the number of deaths
(Yd) caused by COVID-19 in every Brazilian city. From
these data, we create time series of the number of cases
Yc(tc) for each city, where tc refers to the number of days
since the first case reported in each city. Similarly, we cre-
ate time series of the number of deaths Yd(td), where td
refers to the number of days since the first death reported
in each city. By doing so, we group all cities according to
their stage of the disease propagation (as measured by tc
or td) to investigate the evolution of allometric relation-
ships between total cases or deaths and city population
(see Methods).
Figure 1A shows the relation between cases of COVID-
19 and city population on a logarithmic scale (logYc ver-
sus logP ) for different numbers of days since the first case
(tc = 10,29,49 and 69 days). The approximately linear
behavior on logarithmic scale indicates that the number
of cases is well described by a power-law function of the
city population
Yc ∼ P βc , (1)
where βc is the so-called urban scaling exponent [15].
Similarly, Figure 1B shows the association between the
number of casualties and the city population on logarith-
mic scale (logYd versus logP ) for different numbers of
days since the first death (td = 10,24,39 and 54 days).
Again, the results indicate that the number of deaths is
approximated by a power-function of the city population
Yd ∼ P βd , (2)
where βd represents the urban scaling exponent for the
number of deaths. Figure 1C shows the association be-
tween the case fatality rate (Yf = Yd/Yc) and the city
population in a similar fashion
Yf ∼ P βf , (3)
where βf is the scaling exponent for the case fatality rate.
The results of Figure 1 also show the adjusted allo-
metric relationships (dashed lines) and the best fitting
scaling exponents βc, βd, and βf . These exponents ex-
hibit an increasing trend with time so that βc and βd
exceed one after some number of days after the first case
or death. This dynamic behavior is better visualized in
Figure 2, where we depict βc, βd, and βf as a function
of the number of days since the first case (tc) or death
(td). The scaling exponent for the number of cases βc,
which is sub-linear (βc < 1) during the first days, be-
comes super-linear (βc > 1) about tc ≈ 20 days following
the first case, and appears to approach a plateau around
βc ≈ 1.5 as the number of days tc further increases. The
dynamic behavior of the scaling exponent for deaths βd
is similar to βc; however, βd increases slower with time
and becomes super-linear after about td ≈ 40 days since
the first death. This behavior suggests that βd is likely to
be approaching a plateau smaller than the one observed
for βc. Conversely, the increasing behavior of βf has not
shown that its value is saturated.
The super-linear allometry between the number of
cases and city population indicates that large cities tend
to have a higher incidence of COVID-19 cases than small
towns. This becomes evident by estimating the number
of cases per capita from Eq. (1), that is, Yc/P ∼ P βc−1.
Thus, the number of COVID-19 cases per capita increases
with the city population since βc > 1. If we assume
βc ≈ 1.57, the number of cases per capita increases with
population as Yc/P ∼ P 0.57, that is, an 1% raise in the
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FIG. 1. Urban scaling relations of COVID-19 cases and deaths. (A) Relationship between the total of confirmed cases
of COVID-19 (Yc) and city population (P ) on logarithmic scale. Panels show scaling relations for the number of cases on a
particular day after the first case has been reported in each city (as indicated within panels). (B) Relationship between the total
of deaths caused by COVID-19 (Yd) and population (P ) of Brazilian cities (on logarithmic scale). Panels show scaling relations
for the number of deaths on a particular day after the first death has been reported in each city (as indicated within panels).
(C) Relationship between the case fatality rate from COVID-19 (Yf ) and population (P ) of Brazilian cities (on logarithmic
scale). Panels show scaling relations for the case fatality rate on a particular day after the first death has been reported in
each city (as indicated within panels). The markers in (A), (B) and (C) represent cities, and the dashed lines are the adjusted
scaling relations with best-fitting exponents indicated in each plot (βc for cases, βd for deaths, βf for case fatality rate).
population is associated with ≈ 0.57% increase in the in-
cidence of COVID-19 cases. Concrete examples better
illustrate the severe impact of this association. For in-
stance, we expect a metropolis such as Sa˜o Paulo (with≈ 12 million people) to have ≈ 576% more cases per capita
than a medium-sized city such as Maringa´/PR (with≈ 420 thousand people, ≈ 1/30 of Sa˜o Paulo), which in
turn is expected to have ≈ 272% more cases per capita
than a small-sized city such as Parana´ıba/MS (with ≈ 42
thousand people, ≈ 1/10 of Maringa´).
The exponent βc ≈ 1.57 found for cases of COVID-19
is considerably larger than the one reported for the 2009
H1N1 Pandemic in Brazil (βc ≈ 1.2) and somewhat close
to the exponents for HIV in Brazil and United States
(βc ≈ 1.4) [22]. Similarly to what we observe for the cases
of COVID-19, the allometric exponent for HIV cases in
Brazil was initially sub-linear during the 1980s, became
super-linear after the 1990s, and started to approach a
super-linear plateau after the 2000s [22]. However, the
evolution of the allometry for HIV has been much slower
than what we have observed for the COVID-19. Another
interesting point reported by Rocha, Thorson, and Lam-
biotte [22] is that the number of H1N1 cases in Brazil
started to scale linearly with city population in 2010 (one
year after the first outbreak). These authors also argue
that this reduction in the scaling exponent possibly re-
flects a better response for the spread of H1N1 after the
pandemic outbreak. If the behavior observed in the 2009
H1N1 Pandemic generalizes (at least in part) for the cur-
rent COVID-19 pandemic, we would expect a decrease in
values of βc in the future.
Despite being smaller than βc, the allometric exponent
for the number of deaths by COVID-19 βd is larger than
one. This result indicates that large cities are likely to
have proportionally more casualties than small towns.
If the allometric exponent for deaths saturates around
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FIG. 2. Time dependence of the scaling exponents for COVID-19 cases, deaths, and case fatality rate. (A) De-
pendence of the exponent βc on the number of days after the first case of COVID-19 (tc). (B) Dependence of the exponent
βd on the number of days after the first death caused by COVID-19 (td). (C) Dependence of the exponent βf on the number
of days after the first death caused by COVID-19 (td). The shaded regions in all panels represent standard errors, and the
horizontal dashed lines indicate the isometric scaling (βc = βd = 1) in (A) and (B), while in (C) it represents βf = 0. We note
that βc and βd increase with time and appear to approach asymptotic values larger than one. The exponent βf also has an
increasing trend but does not appear yet to approach a plateau.
βd ≈ 1.25, the number of deaths per capita increases with
population as Yc/P ∼ P 0.25. Thus, every 1% raise in
population associates with ≈ 0.25% raise in the number
of deaths per capita. With this exponent, we expect a
metropolis such as Sa˜o Paulo (≈ 12 million inhabitants)
to have ≈ 131% more deaths per capita than Maringa´
(βd ≈ 420 thousand inhabitants). The scaling exponent
for COVID-19 deaths is larger than those reported for
diabetes (βd ≈ 0.8), heart attack (βd ≈ 1) and cerebrovas-
cular accident (βd ≈ 1) in Brazil after the 2000s [22].
Conversely, scaling exponents related to disease mortal-
ity in Brazil displayed a decreasing trend with time, and
values as high as 1.25 were observed for diabetes in 1996
(βd ≈ 1.22) and heart attack in 1981 (βd ≈ 1.25) [22]. The
convergence of these exponents to linear or sub-linear
regimes may reflect the increasing access to medical fa-
cilities in urban areas [22].
Based on currently available data (Figure 2C), it is
hard to confidently assert whether the values of βf will
remain smaller than zero during the long-term course of
the pandemic. However, the persistence of this behav-
ior indicates that the case fatality rate (Yf ) decreases
with city population. By considering the latest estimate,
βf ≈ 0.14, every 1% increase in population associates with
0.14% reduction in the fatality rate. We believe there
are at least three possible explanations for this behavior.
First, it suggests that large cities are testing for COVID-
19 proportionally more than small ones. Second, it may
reflect an “increasing urban advantage” where the larger
the city, the more access to medical facilities and so the
chance of receiving more appropriate treatment against
the coronavirus disease. Finally, a third cause can be as-
sociated with age demographic changes with the city pop-
ulation; specifically, a smaller proportion of older adults
at high risk for severe illness and death from COVID-19
leads to a reduced case fatality rate. Among these three
possibilities, we could not verify the association between
the number of COVID-19 tests and population due to the
lack of data at the city level.
To test for an increasing urban advantage for the treat-
ment of COVID-19, we investigate the scaling relation
between the number of hospital intensive care unit (ICU)
beds and city population. Because critically ill patients
frequently require mechanical ventilation [27, 28], the
number of ICU beds has proved to be crucial for the treat-
ment of COVID-19. Figure 3A shows the allometric re-
lationship between the number of ICU beds from private
and public health systems (Yicu, as of April 2020) and
the population, where a strong super-linear relationship
emerges with scaling exponent βicu ≈ 1.63. We also note
that the scaling law overestimates the number of ICU
beds in large urban areas due to the influence of a large
number of cities having very few ICU beds. However, the
exponent βicu remains super-linear (βicu ≈ 1.44) even if
we consider only cities having more than 500 thousand
people and the number of ICU beds per capita system-
atically increases with population (Supplementary Fig-
ure S1). The super-linear scaling of ICU beds indicates
that large Brazilian cities are more structured to deal
with critically ill patients, which in turn may partially
explain the (present) reduction in the fatality rate with
the city size. It is worth noting that the Brazilian Public
Unified Health System (Sistema U´nico de Sau´de – SUS)
is decentralized and composed by “health regions”, con-
tiguous groups of cities usually formed by a large city and
its neighboring cities [29]. Cities within the same health
region may share medical services, which may in turn
reduce the structural advantages of large urban areas.
We have also investigated how age demographic dis-
tribution changes with city population. Estimates have
shown that the case fatality rate of COVID-19 is substan-
tially higher in people aged more than 60 years (0.32%
for those younger than 60 years versus 6.5% for those
older than 60 years [30]). Thus, the age demographic of
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FIG. 3. Urban scaling of ICU beds, high-risk and low-risk populations. (A) Relationship between the number of ICU
beds (Yicu) and the city population (P ) on logarithmic scale. We observe that the number of ICU beds scales super-linearly
with city size (βicu = 1.63 ± 0.03), indicating an urban advantage for health coverage. (B) Relationship between the high-
risk population (Phr, defined as adults older than 60 years) and the city population (P ) on logarithmic scale. The high-risk
population scales sub-linearly (βhr = 0.93± 0.003), showing that large cities tend to have smaller fractions of elderly than small
cities. (C) Relationship between low-risk population (Plr, defined as adults younger than 60 years) and the city population
(P ) on logarithmic scale. We note that the low-risk population scales almost linearly (βhr = 1.01 ± 0.0004) with city size. The
behavior of these three quantities partially explains the (present) decrease of the fatality rate with population (βf < 0).
cities represents an important factor for the COVID-19
case fatality. Figures 3B and 3C show how the number of
people older (Phr, the high-risk population) and younger
(Plr, the low-risk population) than 60 years change with
the total population (P ). We note that the high-risk
population increases sub-linearly with city size with an
exponent βhr ≈ 0.93, while the low-risk population scales
linearly (βlr ≈ 1) with city size. This result shows that
large cities have a lower prevalence of adults older than
60 years, such that a 1% increase in city population is as-
sociated with a 0.93% raise in the high-risk population.
In a more concrete example, we expect a city with one
million people to have proportionally ≈ 15% fewer adults
older than 60 years when compared with a city of 100
thousand inhabitants. Thus, a low prevalence of elderly
in large urban areas may also partially explain the reduc-
tion in the fatality rate of COVID-19 with the increase
of city population.
In addition to addressing the urban scaling of cases and
deaths of COVID-19, we have investigated associations
between the growth rates of cases and deaths and the city
population. As mentioned, the work of Stier, Berman,
and Bettencourt [24] shows that the initial growth rates
of COVID-19 cases in metropolitan areas of the United
States scale as a power-law function of the population
with an exponent between 0.11 and 0.20. By using our
data and as detailed in Methods, we have estimated the
growth rates of cases (rc) and deaths (rd) for Brazilian
cities. In agreement with the United States case, our re-
sults also indicate that COVID-19 cases initially grow
faster in large cities (Supplementary Figure S2), such
that rc ∼ P βrc with βrc between ≈ 0.1 and ≈ 0.22 during
the first month since the first case of COVID-19 (Sup-
plementary Figures S3 and S4). We also found similar
behavior for the growth rate in the number of deaths rd,
where a power-law relation rd ∼ P βrd is a reasonable de-
scription for the empirical data with a scaling exponent
βrd slightly lower than βrc (Supplementary Figures S2,
S3, and S4).
The growth rate depicts a more instantaneous picture
of the COVID-19 spreading process, and its association
with size may change during the long-term evolution of
the pandemic. These changes may reflect the different
actions taken by each city to face the COVID-19 pan-
demic and other particularities affecting the COVID-19
spreading. For the spreading of COVID-19 in the United
States, Heroy [31] has reported that large cities appear
to enter in an exponential spreading regime earlier than
small ones. To better investigate these possibilities in
our data, we have estimated the average relationship be-
tween the growth rate of cases (rc) and deaths (rd) and
the city rank s (s = 1 represents the largest city in data,
s = 2 the second-largest, and so on) at different periods.
Figure 4A shows the results for the growth rates in the
number of cases (rc). In agreement with the power-law
association between rc and the city population (Supple-
mentary Figure S2A), we note that lower values of the
city rank s are associated with higher growth rates rc in
the initial days since the first cases. However, as time
goes by, the growth rate of cases starts to decrease in
large cities (low-rank values) and to increase in small ones
(high-rank values). This result appears to agree with the
findings of Heroy [31] in the sense that there is a delay in
the emergence of high growth rates of cases between large
and small cities. Figure 4B shows the same analysis for
growth rate in the number of deaths rd. While we also
observe a decrease in rd for large cities and increase for
small ones, the differences in rd are less pronounced than
in rc. It is worth remembering that the time tc (or td) is
measured in days since the first case (or death) for each
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FIG. 4. Association between growth rates and city size. (A) Relationship between the growth rate of COVID-19 cases
(rc) and the city rank (s). The different curves show the average values rc versus s for different number of days since the first
case (tc, as indicated by the color code). (B) Relationship between the growth rate of deaths by COVID-19 (rd) and the city
rank (s). The different curves show the average values rd versus s for different number of days since the first death (td, as
indicated by the color code).
city; thus, the results of Figure 4 do not reflect delays in
the emergence of the first case in each city.
DISCUSSION
We have studied scaling relations for the number of
COVID-19 cases and deaths in Brazilian cities. Similarly
to what happens for other diseases, we found the num-
ber of cases and deaths to be power-law related to the
city population. For both cases and deaths by COVID-
19 the association with population is super-linear, mean-
ing that large cities tend to have a higher incidence of
cases and deaths. Our estimates of the latest values of
the scaling exponents indicate that every 1% increase in
population is related to ≈ 0.57% increase in the number
of cases per capita and to a 0.25% rise in the number
of deaths per capita. Thus, large cities are expected to
be proportionally more affected by the COVID-19 pan-
demic. This result is in line with the findings for other
infectious diseases [20, 22] and probably reflects the ex-
istence of a higher degree of interaction between people
in large cities [16, 23]. Because social distancing is cur-
rently the only available measure to mitigate the impact
of COVID-19, our results suggest that large cities may
require more severe degrees of social distancing policies.
We have also observed that the case fatality rate de-
creases with the city size. Our results indicate that a
1% increase in population associates with ≈ 0.14% re-
duction in the case fatality rate by COVID-19; however,
this reduction has decreased since the beginning of the
pandemic. This behavior can be partially explained by
an “increasing urban advantage” where large cities have
proportionally more ICU beds than small ones. In ad-
dition, changes in age demography with city size shows
that large cities have proportionally less elderly people
who are at high risk for developing severe illness and dy-
ing from COVID-19. This may also partially explain the
reduced case fatality rate with the city population.
In agreement with the results for metropolitan areas
in the United States [24], we have found that large cities
usually display higher growth rates in the number of cases
during the initial spread of the COVID-19. However, our
results also show that these growth rates tend to decrease
in large cities and to increase in small ones in the long-
term course of the pandemic. This behavior suggests
the existence of a delay in the emergence of high growth
rates between large and small cities. Similar behavior
was also found in the United States [31], where large cities
appear to enter an exponential growth regime earlier than
small towns. The existence of this delay suggests that
the initial slow-spreading pace of the COVID-19 in small
cities is likely to be a transient behavior.
Together with the recent findings of Stier-Berman-
Bettencourt [24] and Heroy [31] for the United States,
our results suggest that social distancing policies and
other actions against the pandemic should take in ac-
count the non-linear effects of city size on the spreading
of the COVID-19.
METHODS
Data
The primary data set used in this work was collected
from the brasil.io API [32]. This API retrieves infor-
mation from COVID-19 daily reports published by the
Health Offices of each of the 27 Brazilian federations (26
states and one federation district) and makes it freely
available. This data set comprises information about
the cumulative number of cases and deaths of COVID-19
from 25 February 2020 (date of the first case in Brazil)
until 25 May 2020 (date of our last update) for all Brazil-
ian cities reporting at least one case of COVID-19. The
brasil.io API also provides population data of Brazil-
7ian cities, which in turn relies on population estimates
for the year 2019 released by the Brazilian Institute of
Geography and Statistics (IBGE). There is a total of
3,875 Brazilian cities with at least one reported case of
COVID-19 on 25 May 2020, corresponding to 67% of the
country’s total number of cities. In addition, 1,568 cities
suffered casualties from this disease, representing 28% of
the total. To ensure that our estimates rely on at least
50 cities, we consider a suitable upper threshold for the
time series length. Supplementary Figure S5 shows the
number of cities with time series length longer than a
particular number of days d∗. We find the upper thresh-
old of 69 days for the cumulative number of cases (Sup-
plementary Figure S5A) and 54 days for the cumulative
number of deaths (Supplementary Figure S5B). The data
about age demographics refer to the latest Brazilian cen-
sus that took place in 2010, while the data about the
number of ICU beds are from April 2020. These two
data sets are maintained and made freely available by
the Department of Informatics of the Brazilian Public
Health System (DATASUS) [33].
Fitting urban scaling laws
Urban scaling [15] usually refers to a power-law associ-
ation between a city property Y and the city population
P , and it is expressed by
Y = Y0P β , (4)
where Y0 is a constant and β is the urban scaling ex-
ponent. Equation (4) can be linearized by taking the
logarithmic on both sides, that is,
logY = logY0 + β logP , (5)
where logY and logP are the dependent and indepen-
dent variables of the corresponding linear relationship
between logY and logP . By considering this logarith-
mic transformation, we have estimated the parameters
logY0 and β via orthogonal regression as implemented in
the Python module Scipy [34]. The orthogonal regression
has proved to provide more consistent estimates for scal-
ing exponents [35] and adjusted scaling laws that better
reflect empirical averages of the association between Y
and P [36].
Logarithmic growth rates of cases and deaths
Let us consider that xt (t = 1, . . . , n) represents the
cumulative number of cases (Yc) or the cumulative num-
ber of deaths (Yd) for COVID-19 in a given city at time
t (number of days since first case tc or death td). The
logarithmic growth rate rt at time t is defined as
rt = log(xt/xt−τ)/τ (t = τ, τ + 1, . . . , n) (6)
where τ is a time delay. If we assume the numbers of cases
or deaths to initially increase exponentially (xt ∼ ert,
where r is the exponential growth rate), rt represents
an estimate for the growth rate of this initial exponential
behavior (r). We have estimated rt for the number of
cases (rc) up to tc = 69 days since the first case, while the
growth rate for the number of deaths (rd) is calculated
up to td = 54 days since the first death. These maximum
values for tc and td ensure that we have a sample size of
at least 50 cities when estimating the allometric relations
between the growth rates (rc and rd) and the city popu-
lation (P ). All results in the main text were obtained for
τ = 14 but our discussion is robust for τ between 9 and
21 days (Supplementary Figures S6).
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Supplementary Figure S1. (A) Urban scaling exponent of ICU beds (βicu) when considering cities with more than
500,000 people and (B) ICU beds per capita. We note that the scaling estimated for cities larger than 500,000 people
remains significantly larger than one (βicu = 1.44 ± 0.12) and the number of ICU beds per capita systematically increases with
population. In panel (B), the continuous line represent a Nadaraya-Watson kernel regression for the relation between number
of ICU beds per capita and population.
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Supplementary Figure S2. Urban scaling relations of growth rates of COVID-19 cases and deaths. (A) Relationship
between the growth rate of cases (rc) and the city population (P ) on logarithmic scale. Panels show scaling relations for values
of rc estimated after a given number of days since the first case (as indicated within the panels). (B) Relationship between
the growth rate of deaths (rd) and the city population (P ) on logarithmic scale. Panels show scaling relations for values of
rd estimated after a given number of days since the first death (as indicated within the panels). The markers in (A) and (B)
represent cities, and the dashed lines are the adjusted scaling relations with best-fitting exponents indicated in each plot (βrc
for the growth rate of cases and βrd for the growth rate of deaths).
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Supplementary Figure S3. Time dependence of the scaling exponents for growth rates of cases and deaths.
(A) Dependence of the exponent βrc on the number of days after the first case (tc). (B) Dependence of the exponent βrd on
the number of days after the first death (td). The shaded regions in both panels stand for standard errors, and the horizontal
dashed lines represent βrc = βrd = 0.
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Supplementary Figure S4. Variations in the scaling exponents for the growth rates of cases and deaths under
different values of time delay τ . Panels (A)-(D) show the dependence of the exponent βrc (left panels) and βrd (right
panels) on the number of days after the first case (tc) or death (td) for different values of τ .
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Supplementary Figure S5. Number of cities with time series longer than a particular number of days. (A) The
number of cities reporting cases of COVID-19 with time series larger than d∗ days. The vertical dashed line indicates that
there are 50 cities with confirmed cases time series longer than 69 days. (B) The number of cities reporting deaths caused by
COVID-19 with time series longer than d∗ days. The vertical dashed line indicates that there are 50 cities with deaths time
series longer than 54 days. We have used these thresholds to ensure that our scaling relations are estimated from samples sizes
having at least 50 cities.
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Supplementary Figure S6. Variations in the association between the growth rates and the city rank under different
values of time delay τ . Panels (A)-(D) show the average relationship between the growth rates of COVID-19 cases (rc, left
panels) and (rd, right panels) and the city rank s for number of days after the first case (tc) or death (td) and for different
values of τ (indicated within the plots).
